We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

146 hedge funds and large institutions have $734M invested in Cogent Biosciences in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

70% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 37

56% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $1.13M

34% more capital invested

Capital invested by funds: $547M → $734M (+$187M)

10% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 30

1% more funds holding

Funds holding: 144 → 146 (+2)

2.93% less ownership

Funds ownership: 108.08% → 105.14% (-2.9%)

Holders
146
Holders Change
+2
Holders Change %
+1.39%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
33
Increased
63
Reduced
37
Closed
30
Calls
$1.76M
Puts
$1.13M
Net Calls
+$632K
Net Calls Change
-$13K

Top Buyers

1
State Street
State Street
Massachusetts
+$21.5M
2
KCM
Kynam Capital Management
New Jersey
+$16.4M
3
SI
Sofinnova Investments
California
+$14.8M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.3M

Top Sellers

1
SCM
Suvretta Capital Management
New York
-$21M
2
Morgan Stanley
Morgan Stanley
New York
-$16.5M
3
EAM
Eventide Asset Management
Massachusetts
-$13.1M
4
FLSM
Frazier Life Sciences Management
California
-$6.54M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
HS
51
HighVista Strategies
Massachusetts
$1.89M – – –
Bank of New York Mellon
52
Bank of New York Mellon
New York
$1.89M -$124K -20,085 -7%
SAM
53
Sectoral Asset Management
Quebec, Canada
$1.77M +$1.63M +263,700 New
NLVP
54
New Leaf Venture Partners
New York
$1.69M – – –
Deutsche Bank
55
Deutsche Bank
Germany
$1.61M +$1.25M +201,491 +538%
Macquarie Group
56
Macquarie Group
Australia
$1.55M – – –
PIM
57
Platinum Investment Management
Australia
$1.25M -$1.79M -289,380 -61%
Two Sigma Advisers
58
Two Sigma Advisers
New York
$1.18M +$1.09M +176,290 New
LIP
59
Lighthouse Investment Partners
Florida
$1.13M +$1.04M +167,878 New
CCM
60
Cinctive Capital Management
New York
$978K +$900K +145,514 New
Two Sigma Investments
61
Two Sigma Investments
New York
$946K +$870K +140,710 New
Citadel Advisors
62
Citadel Advisors
Florida
$886K -$3.15M -508,880 -79%
Swiss National Bank
63
Swiss National Bank
Switzerland
$833K +$194K +31,400 +34%
Qube Research & Technologies (QRT)
64
Qube Research & Technologies (QRT)
United Kingdom
$827K +$36.2K +5,849 +5%
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$801K +$19.7K +3,182 +3%
PA
66
Profund Advisors
Maryland
$729K +$377K +60,917 +128%
Barclays
67
Barclays
United Kingdom
$723K -$751K -121,552 -53%
Fisher Asset Management
68
Fisher Asset Management
Washington
$682K -$1.61K -260 -0.3%
CSS
69
Cubist Systematic Strategies
Connecticut
$672K +$408K +66,031 +194%
Susquehanna International Group
70
Susquehanna International Group
Pennsylvania
$625K +$32.1K +5,185 +6%
JP Morgan Chase
71
JP Morgan Chase
New York
$582K -$226K -36,590 -30%
AllianceBernstein
72
AllianceBernstein
Tennessee
$485K – – –
UBS AM
73
UBS AM
Illinois
$467K +$61.8K +10,000 +17%
Mirae Asset Global Investments
74
Mirae Asset Global Investments
South Korea
$446K +$24.2K +3,912 +8%
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$432K +$54.4K +8,804 +16%
1 2
3
4 5

COGT Hedge Fund Activity: Q1 2024 in Review

146 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q1 2024, worth a combined $734M — up 34% from $547M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new COGT positions and 30 closed out — a net gain of 3 holders — while 63 added to existing stakes and 37 trimmed.

The largest buyer was State Street, adding an estimated $21.5M. The largest seller was Suvretta Capital Management, cutting an estimated $21M.

  • 146 institutional investors held Cogent Biosciences (COGT) as of Q1 2024, up from 144 in Q4 2023.
  • Funds reported $734M of Cogent Biosciences stock for Q1 2024, up 34% quarter-over-quarter.
  • 33 funds opened new Cogent Biosciences positions in Q1 2024 and 30 closed out, a net change of +3 holders.
  • The largest Cogent Biosciences buyer in Q1 2024 was State Street, an estimated $21.5M added.
  • The largest Cogent Biosciences seller in Q1 2024 was Suvretta Capital Management, an estimated $21M sold.

Based on aggregated 13F filings for Q1 2024.